Charles River Labs Intl buy Wells Fargo & Company
Start price
22.09.23
/
50%
€188.80
Target price
22.09.24
€257.73
Performance (%)
-6.14%
Price
28.08.24
€177.20
Summary
This prediction is currently active. With a performance of -6.14%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 22.09.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -0.165% | -0.165% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Company from $280.00 to $275.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat